Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Celsa

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Scientific Reports|November 23, 2025
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus BevacizumabAndrea Dalbeni, Filippo Cattazzo, Marco Vicardi, et al.
Frontiers in Medicine|June 12, 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter studyOliviero Riggio, Ciro Celsa, Vincenza Calvaruso, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidenceGiulia Francesca Manfredi, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Hepatology (Baltimore, Md.)|August 3, 2022
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction modelFrancesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, et al.
Journal of Hepatology|April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.
Oncology and Therapy|May 20, 2026
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in ItalyGiuseppe Cabibbo, Caterina Cocuzza, Ciro Celsa, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Scientific Reports|November 23, 2025
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus BevacizumabAndrea Dalbeni, Filippo Cattazzo, Marco Vicardi, et al.
Frontiers in Medicine|June 12, 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter studyOliviero Riggio, Ciro Celsa, Vincenza Calvaruso, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidenceGiulia Francesca Manfredi, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Hepatology (Baltimore, Md.)|August 3, 2022
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction modelFrancesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, et al.
Journal of Hepatology|April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.
Oncology and Therapy|May 20, 2026
Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in ItalyGiuseppe Cabibbo, Caterina Cocuzza, Ciro Celsa, et al.
Pageof 12